Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3038
Source ID: NCT00162357
Associated Drug: Technetium Tc99m Sestamibi
Title: Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2|Coronary Restenosis
Interventions: DRUG: Technetium Tc99m Sestamibi
Outcome Measures: Primary: Evaluate symptom-free heart blockages that develop following initial opening in patients with Type II diabetes mellitus based on Cardiolite imaging | Secondary: Determine how often symptom-free heart blockages occur 5-6 months after opening in patients with Type II diabetes mellitus|Examine the relative value of ejection fraction, summed stress, rest, and difference MPI scores for identifying patients with cardiac events during 18 month follow-up.|Compare patient hospital and out-patient cost for cardiac care for each group of patients (MPI versus standard care).
Sponsor/Collaborators: Sponsor: Lantheus Medical Imaging
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 106
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Start Date: 2004-04
Completion Date: 2005-12
Results First Posted:
Last Update Posted: 2011-04-15
Locations: Local Institution, Hartford, Connecticut, United States|Local Institution, Waterbury, Connecticut, United States|Local Institution, Grand Rapids, Michigan, United States|Local Institution, Roslyn, New York, United States|Local Institution, Burlington, Vermont, United States|Local Institution, Roanoke, Virginia, United States|Local Institution, Wausau, Wisconsin, United States|Local Institution, San Juan, Puerto Rico
URL: https://clinicaltrials.gov/show/NCT00162357

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress